JACKSON, Miss. — On Wednesday, June 1, patients can submit their applications for a medical marijuana card in Mississippi.
Online registration for all types of medical cannabis licensing will be available online starting at 8 a.m.
According to the state’s website, applications will be accepted for all services, facilities, and individuals regulated by the Mississippi State Department of Health.
- Individuals: patients and medical practitioners
- Facilities: cannabis cultivation, processing and testing
- Services: cannabis transportation and waste disposal
The Mississippi Department of Revenue will be responsible for the licensing of medical cannabis dispensaries beginning in July.
Once the application process begins, there will be a 30-day approval time for licensure applications and a five-day approval time for program patients.
All applications will go through the Mississippi State Health Department and require a physician’s approval.
If you plan on working with, certifying or using medical cannabis, the state asks that you review the pre-application checklist first. CLICK HERE for the checklist.
The following medical conditions or their treatment qualify for participation in the Mississippi Medical Cannabis Program:
- Parkinson’s disease
- Huntington’s disease
- muscular dystrophy
- spastic quadriplegia
- positive status for human immunodeficiency virus (HIV)
- acquired immune deficiency syndrome (AIDS)
- amyotrophic lateral sclerosis (ALS)
- Crohn’s disease
- ulcerative colitis
- sickle-cell anemia
- Alzheimer’s disease
- agitation of dementia
- post-traumatic stress disorder (PTSD)
- pain refractory to appropriate opioid management
- diabetic/peripheral neuropathy
- spinal cord disease or severe injury
Also qualifying is a chronic terminal or debilitating disease or medical condition or its treatment that produces one or more of the following:
- cachexia or wasting syndrome
- chronic pain
- severe or intractable nausea
- severe and persistent muscle spasms including, but not limited to, those characteristic of multiple sclerosis
©2022 Cox Media Group
Read the full article here